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Abstract Phosphatidylinositol synthase (CDP-1,2-diacyl-sn- 
glycerol: 3-phosphatidyltransferase, EC 2.7.8.11) catalyzes the 
formation of phosphatidylinositol and CMP from CDP-diacyl- 
glycerol and myo-inositol. We have cloned a phosphatidylinositol 
synthase cDNA from rat brain by functional complementation of
the yeast pis mutation, which is defective in phosphatidyfinositol 
syuthase. The deduced protein comprised 213 amino acids with a 
calculated molecular mass of 23 613 Da. The predicted protein 
sequence is highly homologous to the previously determined yeast 
phosphatidylinositol synthase sequence. The eDNA hybridized to 
a 1.7-kb mRNA that was abundantly expressed in rat brain and 
kidney. 
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1. Introduction 
Phosphatidylinositol (PI) occurs widely in amounts usually 
corresponding to 2 12% of the total phospholipids in cells [1]. 
Besides being an essential component of the cell membrane, 
PI plays an important role in anchoring proteins to the mem- 
brane and is the precursor to signaling molecules uch as 
polyphosphoinositides and diacylglycerol [2,3]. The enzyme 
responsible for the final step of de novo biosynthesis of PI 
is PI synthase (CDP-1,2-diacyl-sn-glycerol: 3-phosphatidyl- 
transferase, EC 2.7.8.11), which catalyzes the reaction of 
CDP-diacylglycerol and myo-inositol (inositol) to form PI 
and CMP [4,5]. This enzyme is membrane-associated an , in 
animal tissues, is localized primarily in the endoplasmic reti- 
culum and the Golgi [6,7]. Recently, however, enzyme activity 
was measured in plasma membranes isolated from GH3 pitui- 
tary cells [8]. Moreover, the existence of two forms of PI 
synthase in pituitary cells has been postulated on the basis 
of different kinetic characteristics between the endoplasmic- 
reticulum and the plasma-membrane e zymes [8,9]. 
The first purification of PI synthase was performed in the 
yeast Saccharomyces cerevisiae by Fischl and co-workers [10], 
who also characterized its enzymatic properties [11]. Purifica- 
tion was achieved by affinity chromatography with CDP-dia- 
cylglycerol after solubilization of the microsomes with Triton 
X-100. The purified enzyme was shown to have a molecular 
weight of 34000 as determined by SDS-polyacrylamide g l 
electrophoresis (SDS-PAGE). Several attempts have been 
made to purify mammalian PI synthase, but with limited suc- 
cess [12-15]. Recently, PI synthases have been purified from 
human placenta [16] and rat liver [17], and determined tohave 
molecular masses of 24000 Da and 21000 Da, respectively, 
when analyzed by SDS-PAGE. 
In spite of the obvious importance of PI synthase in mam- 
malian cells, attempts to isolate eDNA clones that encode this 
enzyme have been unsuccessful. However, in the yeast S. ce- 
revisiae, Nikawa and Yamashita [18] have isolated a gene 
(PIS) encoding PI synthase. The PIS open reading frame en- 
coded 220 amino acids with a calculated molecular weight of 
24 823 and was indispensable for cell growth [19]. 
Here we report the cloning of the first mammalian PI 
synthase cDNA by functional complementation f a yeast 
pis mutant defective in PI synthase activity [20] with a rat 
brain cDNA library. The cDNA encoded 213 amino acids 
with a calculated molecular mass of 23 613 Da. Comparison 
of the predicted sequence with the yeast PIS gene product [19] 
revealed 39% identity. 
2. Materials and methods 
2.1. Yeast strains, media nd transformation 
The PI synthase mutant strain D278-2A (MAT~ pis leu2 his4) and 
the wild-type strain D451-3 (MATa leu2 ura3 canl) have been de- 
scribed [18,21]. Cloning host strain D501-1 (MATa pis leu2 ura3) 
was derived from a cross of D278-2A and D451-3. Cells were grown 
aerobically with shaking at 30°C unless otherwise stated. The compo- 
sition of inositol-depleted minimum medium (M-i) was as described 
[22]. Inositol-supplernented minimum medium (M20i) was prepared 
by supplementing M-i medium with 20 ~tg of inositol/ml. When nec- 
essary, e-leucine and uracil were added to the culture medium at a 
concentration f 20 I.tg/ml. Yeast transformation was performed by 
the lithium acetate method [23]. 
2.2. cDNA library, DNA manipulations, and sequencing 
A rat brain cDNA library was prepared as described previously 
[24]. Escherichia coli plasmids were prepared using Wizard Minipreps 
(Promega). Yeast plasmids were extracted as described [18]. DNA 
sequencing was performed by the dideoxy chain-termination method, 
using a Taq dye primer cycle sequencing kit and an ABI 373A DNA 
sequencer (Applied Biosystem). The final sequence was confirmed 
from both strands. 
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2.3. PI synthase assay 
PI synthase activity was assayed by measuring the incorporation of
[3H]inositol (Amersham) into PI in the presence ofCDP-diacylglycer- 
ol. The standard reaction mixture contained 50 mM Tris-HC1 (pH 
8.0), 20 mM MgC12, 100 I.tM CDP-diacylglycerol, 0.3% Triton X- 
100, 0.57 mM [3H]inositol (~ 4 × 104 dpm/nmol), and membrane pro- 
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tein (10-50 pg) in a total volume of 0.1 ml. The reaction was allowed 
to proceed for 10 rain at 37°C. The extraction and determination fPI 
were performed according to Parries and Hokin-Neaverson [14]. The 
membrane fraction of yeast cells, which had been cultured in medium 
M20i at 36°C, was prepared as previously described [25]. An enzyme 
unit is defined as the amount of enzyme that catalyses the formation 
of 1 pmol of PI in 1 min. 
2.4. Rapid amplification ofcDNA ends 
5' rapid amplification of cDNA ends (RACE) was carried out using 
the 5' Ampli FINDER RACE kit (Clontech) and rat brain 5'-RACE 
Ready cDNA (Clontech) according to recommendations given by the 
supplier. For the first and second polymerase chain reaction (PCR), 
5'-GGAAATGATGGCGAAAACAATCCGG-Y (primer 1, comple- 
mentary to nt 193-217) and 5'-GCAAGCTTAAGATTAGGCAC- 
GAACAGGAAG-Y (primer 2, complementary to nt 160- 
181 +GCAAGCTT) were used, respectively. A HindlII site 
(AAGCTT) was engineered at the 5' end of the primer 2. The second 
PCR products were fractionated on an agarose gel and visualized by 
staining with ethidium bromide. An intensely stained band of ~ 250 
bp was excised from the gel, digested with EcoRI and HindlII, and 
ligated into the EcoRI/HindlII site of Bluescript II KS- (Stratagene) 
to produce plasmid pBS/race. Three independent inserts were se- 
quenced. 
3. Results and discussion 
3.1. Cloning strategy 
Previously, we isolated a Km mutant of S. cerevisiae with a 
lesion in PI synthase [20]. The mutant, strain 423, requires a 
high concentration of inositol for growth and possesses an 
enzyme with an apparent Km for inositol over 200-times high- 
er than that of wild-type enzyme. To clone mammalian PI 
synthase cDNA, we used strain D501-1 (MATa pis leu2 
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Fig. 1. PI synthase activity of the pis transformant expressing rat PI 
synthase. D501-1 cells harboring pPIS3 (e) and D501-1 cells har- 
boring pDB20 (O) were grown at 36°C in 250 ml of M20i medium 
supplemented with leucine to the mid-logarithmic phase. The cells 
were harvested by centrifugation and membrane fractions were ob- 
tained. PI formation was determined with the indicated amounts of 
membranes under standard assay conditions. 
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GTGGATC GCCC GGGAGAAC TGGGCCCAGGGCTCAGGTGGAGC TGCC GATGCCC GGGCTG 60 
AAAGGTGAGACCAC GCTGGTGAGGCTGGGACAAGACCTTGCACCTCCAGACCTGGGCC GA 120 
GACCACAAGGGGAGCCGCCAAGATGC CAGAGGAAAATATC TTCCTGTTCGTGC TAATCT 180 
M P E E N I F L F V P N L 
TATTGGTTATGC CGGATTGTTTTCGCCATCATTTCCTTCTAC TTATGCCCTGCTGCCC 240 
I G Y A R I V F A I I S F Y F M P C C P 
CTTCAC GGCC TCC TC C TTC TATC TACTCAGCGGACTTCTAGACGC TTTCGATGGACAC GC 300 
F T A S S F Y L L S G L L D A F D G H A 
AC-CTC GAGC C CTTAATCAAGGAACCCGATTTGGGGC CATGC TC GACATGCTGAC GGACCG 360 
A R A L N Q G T R F G A M L D M L T D R 
TTGCGCCACCATGTGTCTC TGGTCAAC TGGCC TGCTC TACCCTCC-C-C-CCAC TC TTC T 420 
C A T M C L L V N L A L L Y P R A T L L 
GTTCCAGCTCAC-CATGAGCC TGGACGTGGCCAGTCACTGGCTGCATCTGCACAGTTC TGT 480 
F Q L S M S L D V A S ~ W L H L H S S V 
GGTGC GAGGCAGTGAGAGCCACAAGATGATTGAC C TGTCTGGGAAC  CTGTGCTTCGAAT 540 
V R G S E S H K M I D L S G N P V L R I 
CTACTATACTTCCAGGCC TGCTC TGTTCACC CTGTGTGC TGGAAATGAAC TC TTCTAC TG 600 
Y Y T S R P A L F T L C A G N E L F Y C 
C CTCCTGTACCTGTTCAATTTCTCCGAGGGACCACTAGTC G CTCTGTGGGGCTTTTCCG 660 
L L Y L F N F S E G P L V G S V G L F R 
AATC-GGC C TCTGGATCACAGCTCC CATTGC CCTGCTCAAGTC ATCATTAGTGTCATCCA 720 
M G L W I T A P I A L L K S I I S V I H 
CC TCGTCAC GGCTGCAAGGAACATGC-C TGCC CTCGATGCAGCAGACCGC C- CAAGAAGAA 780 
L V T A A R N M A A L D A A D R A K K K 
ATGATC CTC TCCCATCC C CAGCTGC CACC TGCC C TC-GGTATC TACTGTGCCACATGGCT 840 
CCTCTC C TCC TAAGAGGTC  CAGTGTCATGTCTTTCTCATGTGTTCTCTAACCTGC GG 900 
ATTGGGGGTCACCCTCTGTTTGGTC¢I'fCVI~AC TGTCTTTTTACTCCTGATAACTAGACCC 960 
AAC CCGTGACCCCAAGGACC TGGCACTGCAAAGCAGGAAGGGTGC TCAGGAGGC CAC TC 1020 
ATCCAGCCGGTGCTCCAGGAGGCCTGTCTGAAGAC~CACATATC CTGCTGG 1080 
ATCAGCC TGGGGTC TGGCCTGAGACTTTGGGAAC TTATAC GGGCAAAGGAGTCAGGC TGA 1140 
TGGGC AAGAAGGCTGGGGTAC CAGGC AGGGAGGGAAGGGGCCAAGGGCCAAC TAGATC 1200 
TTTCC CTTA CAAGCTCCTCTATC TGTC CTGC TCTGGAAACCTCCATAATAAAGGGGG 1260 
GCACCTTCACTC'~'x ' I "~ 'x~. IATTTGTTTAC~TCTTAGATGATGGCCTAGGGT 1320 
TCAAAGGAGCTGGGTAAAAAAAAAAGAAATCCAC TGGATGCTTTTC CACAAA~ 1380 
TGGC TCCTCCCTGTCATTCCAGTGACC TCAGAGAGGCCTCGAGGTTCACAAC42GTTGTC C 1440 
TGCCCAC TGC TCTATGTC C TGGCTGGC AC TTTCAC TGTAACCT,I~TG.£-£-I-x-I~aACC C 1500 
TCATGAGAATGTAAGCTTCACAAGAGCAGATTTAGATCTTTCTCGTC T TG CTGGAGTG 1560 
AAAAGTAGCC TGGCATGTGGTAACTGC TTAATAAATATTCATGGAAAGATGAAAAAAATA 1620 
C 1621 
Fig. 2. Nucleotide sequence of PI synthase cDNA and the deduced 
amino acid sequence. Isolated clones (pPIS3 and pPIS5) and the 5' 
RACE product are combined to construct he composite cDNA. 
The largest open reading frame is translated into an amino acid se- 
quence and shown below the nucleotide sequence in the single-letter 
code. The numbers at the right denote the positions of the last nu- 
cleotide of each line. The stop codon is indicated by an asterisk. 
The sequence reported in this paper has been deposited in the Gen- 
Bank data base (accession o. D82928). 
ura3), a derivative of strain 423, which was constructed using 
standard genetic methods. The strain can grow in inositol- 
supplemented minimum medium M20i, but not in inositol- 
depleted minimum medium M-i, like the original 423 strain. 
Transformation of the mutant with PI synthase cDNA should 
restore growth in medium M-i. Thus, we thought that a PI 
synthase cDNA could be identified by complementation f the 
pis mutation. 
3.2. Cloning of rat PI synthase cDNA 
Competent cells were prepared and transformed with a rat 
brain cDNA library [24] by the lithium acetate method [23]. 
The library had been constructed in a yeast expression vector, 
pDB20 [25], containing the ADH1 promoter and terminator, a
NotI cloning site, and URA3 as a selectable marker. Thus the 
cDNA could be expressed under the control of ADH1 pro- 
moter in yeast cells. We used about 50 p.g DNA of the library 
per 109 cells. The transformants were cultured on medium M-i 
agar plates (diameter, 9 cm) supplemented with leucine at 
30°C for 12 h, followed by further incubation at 36°C for 5 
days. From 10 such plates, we obtained 8 independent colo- 
nies. Seven plasmids recovered from these transformants com- 
plemented the pis mutation after retransformation of strain 
D501-1. Restriction analysis revealed that the plasmids could 
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be classified into two groups (plasmids pPIS3 and pPIS5) and 
that the two clones contained overlapping cDNA inserts of 
1.5 and 1.2 kbp, respectively. 
To confirm that the cDNA clone pPIS3 which contained a
longer insert cDNA than pPIS5 encoded PI synthase, we as- 
sayed the enzyme activity. Membrane fractions were prepared 
from D501-1[pDB20] and D501-1[pPIS3] cells which had been 
cultured in medium M20i, and were used for a PI synthase 
assay (Fig. 1). The membranes from the pis mutant harboring 
control plasmid pDB20 synthesized very low amounts of PI 
(spec. act. < 0.1 mU/mg protein) under standard assay con- 
ditions, since the mutant enzyme possesses a very low affinity 
for inositol [20]. However, the pPIS3 transformant expressed 
considerable PI synthase activity. The specific activity was 
9.21 mU/mg protein, which was comparable to or even higher 
than that detected in rat tissue [12,17]. The enzyme activity of 
the pPIS3 transformant was absolutely dependent on CDP- 
diacylglycerol (specific activity in the absence of CDP-diacyl- 
glycerol, < 0.01 mU/mg protein). The apparent Km for inosi- 
tol was estimated to be 0.6 raM. This value was two orders of 
magnitude lower than that of the enzyme in the host pis mu- 
tant cells [20]. When the enzyme was assayed in the presence 
of 10 mM EDTA in stead of MgC12, its activity decreased by 
82% of that assayed under standard assay conditions. Thus, 
we concluded that the cloned cDNA encoded a considerable 
length, if not the full-length, of rat PI synthase. 
3.3. Sequence analysis of  the rat brain PI synthase cDNA 
We next sequenced the two inserts in plasmids pPIS3 and 
pPIS5. Plasmid pPIS3 contained 1496 nt from positions 136 
to 1631, and plasmid pPIS5 contained 1187 nt from positions 
91 to 1277 (Fig. 2). The nucleotide sequences overlapped, 
indicating that they were derived from an identical transcript. 
Within the sequences there existed an open reading frame of 
213 amino acids with a predicted molecular mass of 23 613 Da 
(Fig. 2). However, as there were no stop codons upstream of 
the predicted start methionine, it was not clear that the 
cDNAs encoded the full-length protein. In order to extend 
the insert cDNAs in the 5' direction, we used RACE PCR 
[26,27]. This resulted in the identification of an additional 91 
nt preceding the 5' end of the pPIS5 clone. Two in-frame stop 
codons were found in the 5' RACE product. We constructed 
the composite cDNA by combining pPIS3, pPIS5 and the 5' 
RACE product. The nucleotide and deduced amino acid se- 
quences for the coding region of the composite cDNA are 
presented in Fig. 2. We assumed the ATG codon at positions 
MPEENI  FLFVPNL IGYARIVFA I  I S FYFMPCCPFTASS FYLLSGLLDAFDG 51 ' 
HAARALNOGTRFGAML DMLTDRCATMCLLVNLALLYPRATLL  FOLS MSLDVAS HWL HLH S 111 ' 
: :  : :  . . . : : . ; : : . : : : . . ;  : .  : . ; : ,  . . : : :  , . : : . . ; : . , : . . .  
TMARKYNQVSSLGAVL DMVTDRS TAGLMC FLCVQYpQwCVFFQLMLGL D I TSHYMHMYA 120" 
SVVRGS E SH EM I DL S GNPVLR I YYTS RPALFTLCAGNEL FYC LL yL FNF SEGPLVGSVGL 171 ' 
: .  : . . : : :  . . . . . . .  : . . : : : . :  . : : : . : :  . . . .  : . . . . . .  
SLSAG~TS~r, SVGEG~Sr~U~yrr~ I~4/ /~4AC~,~Q~S,~IT~I - -  - 178" 
FRMGLWITAP IALLKS I I SV I  HLVT~DAADRAKKK 213 ' 
• . .  1 . . .  . . :  . . : . . :  : :  . : .  : :  . . . : .  
-WTT I - I S FP GYVFKOTANVVQLKRAAL I LADNDAKNANE KNKTY 221" 
Fig. 3. Sequence comparison. The deduced amino acid sequence of 
the rat brain PI synthase (upper line) is compared with that of the 
S. cerevisiae nzyme (lower line). Colons indicate identical amino 
acids, and dots conservatively substituted amino acids. The figures 
at the right denote the positions of the right-end amino acids. 
A 
1 2 3 4 5 6 7 8 
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Fig. 4. Expression of PI synthase mRNA in rat tissues. (A) A nylon 
membrane containing poly(A) + RNA from various tissues (Clon- 
tech) was used for the Northern analysis [35]. The blot was hybri- 
dized with a 1.5-kbp cDNA fragment from pPIS3. (B) Same blot 
was rehybridized with a manufacturer-supplied ~-actin probe, riP-la- 
beled probes were prepared using a Megaprime DNA labeling kit 
(Amersham International). Lanes 1-8 contain, in order, 2 lag of 
RNA from rat heart, brain, spleen, lung, liver, skeletal muscle, kid- 
ney, and testis. Size markers are indicated on the right. 
143-145 was the translational initiation codon for the follow- 
ing reasons. First, two in-frame stop codons were located at 
positions 59-451 and 80-82. Second, the predicted protein mo- 
lecular weight compares fairly well to those estimated by SDS- 
PAGE of purified human placenta and rat liver enzymes 
[16,17]. 
3.4. Structural properties of rat PI synthase 
The predicted rat PI synthase is an extremely hydrophobic 
protein, composed of 60% hydrophobic, 20% hydrophilic and 
20% neutral amino acid residues. A more detailed analysis of 
its hydrophobicity was carried out using the computer pro- 
gram of Kyte and Doolittle [28]. Its grand average hydropa- 
thy score was 0.60, comparable to the scores of most integral 
membrane proteins [28]. The PI synthase contains everal hy- 
drophobic stretches within its sequence. Among them, 
stretches encompassing residues 17-35 (average hydropathy 
index, 1.62), 77-98 (average hydropathy index, 1,50) and 
165-195 (average hydropathy index, 1.68) are sufficiently ex- 
tended and hydrophobic to be membrane-associated. We 
searched the protein data base for similar sequences using 
the FASTA program [29]. As expected, S. cerevisiae PI 
synthase was found to bear significant sequence similarity to 
the predicted rat PI synthase (Fig. 3). 39% of the amino acids 
are identical and 73% are similar in the two predicted se- 
quences. Furthermore, rat PI synthase had a region showing 
a high degree of local homology to the conserved omains in 
phospholipid-synthesizing e zymes and amino alcohol phos- 
photransferases of E. coli, S. cerevisiae, and Bacillus subtilis 
92 
[30-34]. The consensus equence, DGX2ARXsGX3DX3D, in 
the four enzymes of S. cerevisiae (PI synthase, phosphatidyl- 
serine synthase, cholinephosphotransferase and ethanolamine- 
phosphotransferase) [31], E. coli phosphatidylglyceropho- 
sphate synthase [30], and B. subtilis phosphatidylserine 
synthase [34] was found in residues 50-72 of rat PI synthase. 
3.5. Tissue distribution of PI synthase mRNA 
The distribution of rat PI synthase mRNA in various tis- 
sues was investigated by probing a gel blot of size-fractionated 
poly(A) + mRNA from rat heart, brain, spleen, lung, liver, 
skeletal muscle, kidney and testis with a radiolabeled fragment 
of the rat brain cDNA. As shown in Fig. 4, a single transcript 
of 1.7-kb was detected in all tissue types tested with varying 
abundance. The transcript was expressed in the brain and 
kidney abundantly and to much lesser extent in the testis. 
There may be an other form (isozyme) of PI synthase in 
tissues which expressed a low amount of the 1.7-kb transcript, 
since the enzyme is considered to be essential for the growth 
of all cell types. 
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